Table 1 Baseline information of patients.

From: Risk factors for discontinuation of intravenous patient-controlled analgesia after general surgery: a retrospective cohort study

Variable

Mean (SD) or N (%)

Age, year (mean, SD)

60.65 (14.28)

Female sex—no (%)

4301/8745 (49.18)

LOS after surgery, day

7.28 (9.50)

Medical history—no./total no. (%)

 DM

767/8745 (8.78)

 HTN

1313/8745 (15.04)

 CKD

218/8745 (2.49)

 Heart disease

275/8745 (3.14)

 Brain disease

239/8745 (2.73)

 Liver disease

678/8745 (7.75)

Anesthesia

 General anesthesia

8716/8745 (99.67)

 Spinal anesthesia

29/8745 (0.33)

ASA physical status classification

 1

1539/8745 (17.60)

 2

5579/8745 (63.80)

 ≥ 3

1627/8745 (18.60)

Laparoscopy

5822/8745 (66.58)

Type of surgery

 Stomach

1894/8745 (21.66)

 Colon

2391/8745 (27.34)

 Hepato-pancreatic-biliary

1244/8745 (14.23)

 Breast

1002/8745 (11.46)

 Small bowel

357/8745 (4.08)

 Transplantation

155/8745 (1.77)

 Vascular

62/8745 (0.71)

 Others

1640/8745 (18.75)

PCA type

 Opioid included

8303/8745 (94.95)

 NSAID only

442/8745 (5.05)

 Background infusion

4382/8745 (50.11)

Preoperative drug usage

 NSAID

448/8745 (5.12)

 Paracetamol

588/8745 (6.72)

 Opioid

640/8745 (7.32)

  1. LOS length of hospital stays, DM diabetes mellitus, HTN hypertension, CKD chronic kidney disease, ASA American Society of Anesthesiologists, PCA patient-controlled analgesia, NSAID non-steroidal anti-inflammatory drug.